Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

2.

Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization.

Walstab J, Steinhagen F, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2011;63(1):45-53.

3.

Involvement of central beta2-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats.

Malinowska B, Zakrzeska A, Kurz CM, Göthert M, Kwolek G, Wielgat P, Braszko JJ, Schlicker E.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Apr;381(4):349-60. doi: 10.1007/s00210-010-0497-6. Epub 2010 Mar 3.

PMID:
20198363
4.

Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.

Combrink S, Kostanian A, Walstab J, Barann M, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2009 Sep-Oct;61(5):785-97.

5.

Urethane, but not pentobarbitone, attenuates presynaptic receptor function in rats: a contribution to the choice of anaesthetic.

Kurz C, Baranowska U, Lupiński S, Göthert M, Malinowska B, Schlicker E.

Br J Pharmacol. 2009 Aug;157(8):1474-82. doi: 10.1111/j.1476-5381.2009.00315.x.

6.

Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.

Haenisch B, Linsel K, Brüss M, Gilsbach R, Propping P, Nöthen MM, Rietschel M, Fimmers R, Maier W, Zobel A, Höfels S, Guttenthaler V, Göthert M, Bönisch H.

Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):1013-6. doi: 10.1002/ajmg.b.30912.

PMID:
19105200
7.

Regulatory mechanisms underlying agmatine homeostasis in humans.

Haenisch B, von Kügelgen I, Bönisch H, Göthert M, Sauerbruch T, Schepke M, Marklein G, Höfling K, Schröder D, Molderings GJ.

Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G1104-10. doi: 10.1152/ajpgi.90374.2008. Epub 2008 Oct 2.

8.

Anandamide effects on 5-HT(3) receptors in vivo.

Rácz I, Bilkei-Gorzo A, Markert A, Stamer F, Göthert M, Zimmer A.

Eur J Pharmacol. 2008 Oct 31;596(1-3):98-101. doi: 10.1016/j.ejphar.2008.08.012. Epub 2008 Aug 24.

PMID:
18775693
9.

Methanandamide allosterically inhibits in vivo the function of peripheral nicotinic acetylcholine receptors containing the alpha 7-subunit.

Baranowska U, Göthert M, Rudz R, Malinowska B.

J Pharmacol Exp Ther. 2008 Sep;326(3):912-9. doi: 10.1124/jpet.108.140863. Epub 2008 Jun 20.

PMID:
18567834
10.

Characterization of an antiproliferative effect of imidazoline receptor ligands on PC12 cells.

Molderings GJ, Göthert M, von Kügelgen I.

Pharmacol Rep. 2007 Nov-Dec;59(6):789-94.

11.

5-HT receptor regulation of neurotransmitter release.

Fink KB, Göthert M.

Pharmacol Rev. 2007 Dec;59(4):360-417. Review. Erratum in: Pharmacol Rev. 2008 Mar;60(1):142.

PMID:
18160701
12.

Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.

Walstab J, Combrink S, Brüss M, Göthert M, Niesler B, Bönisch H.

Anal Biochem. 2007 Sep 15;368(2):185-92. Epub 2007 Jun 8.

PMID:
17617370
13.

S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands.

Molderings GJ, Bönisch H, Brüss M, Wolf C, von Kügelgen I, Göthert M.

Neurochem Int. 2007 Dec;51(8):476-85. Epub 2007 May 7.

PMID:
17559976
14.

Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.

Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M.

Mol Pharmacol. 2007 Jul;72(1):8-17. Epub 2007 Mar 28.

PMID:
17392525
15.

Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin.

Wolf C, Brüss M, Hänisch B, Göthert M, von Kügelgen I, Molderings GJ.

Mol Pharmacol. 2007 Jan;71(1):276-83. Epub 2006 Oct 17.

PMID:
17047095
16.
18.

Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.

Schultheiss T, Flau K, Kathmann M, Göthert M, Schlicker E.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):139-46. Epub 2005 Sep 30.

PMID:
16195872
19.

WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function.

Przegaliński E, Göthert M, Frankowska M, Filip M.

Eur J Pharmacol. 2005 Jul 4;517(1-2):68-73.

PMID:
15961074
20.

Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.

Brüss M, Kiel S, Bönisch H, Kostanian A, Göthert M.

Neurochem Int. 2005 Aug;47(3):196-203.

PMID:
15896881
21.

The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction.

Brüss M, Kostanian A, Bönisch H, Göthert M.

Pharmacogenet Genomics. 2005 Apr;15(4):257-64.

PMID:
15864118
22.

Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.

Kwolek G, Zakrzeska A, Schlicker E, Göthert M, Godlewski G, Malinowska B.

Br J Pharmacol. 2005 Jul;145(5):567-75.

23.
24.

Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.

Kurzwelly D, Barann M, Kostanian A, Combrink S, Bönisch H, Göthert M, Brüss M.

Pharmacogenetics. 2004 Mar;14(3):165-72.

PMID:
15167704
25.

Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Barann M, Schmidt K, Göthert M, Urban BW, Bönisch H.

Br J Pharmacol. 2004 Jun;142(3):501-8. Epub 2004 May 17.

26.
27.

Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines.

Molderings GJ, Bruss M, Bonisch H, Gothert M.

Ann N Y Acad Sci. 2003 Dec;1009:75-81.

PMID:
15028572
28.

Gastrointestinal uptake of agmatine: distribution in tissues and organs and pathophysiologic relevance.

Molderings GJ, Heinen A, Menzel S, Lübbecke F, Homann J, Göthert M.

Ann N Y Acad Sci. 2003 Dec;1009:44-51. Review.

PMID:
15028569
29.

Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferation.

Kribben B, Heller J, Trebicka J, Sauerbruch T, Brüss M, Göthert M, Molderings GJ.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):160-5. Epub 2004 Jan 15.

PMID:
14727007
30.
31.

Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines.

Heinen A, Brüss M, Bönisch H, Göthert M, Molderings GJ.

Int J Colorectal Dis. 2003 Jul;18(4):314-9. Epub 2003 Feb 20.

PMID:
12774246
32.

Modulation of noradrenaline release in human cardiovascular tissues.

Göthert M.

Pharmacol Toxicol. 2003 Apr;92(4):156-9. Review. No abstract available.

PMID:
12753416
33.

Molecular structure of the rabbit alpha2A-adrenoceptor: a contribution to the alpha2A-adrenoceptor versus I1 imidazoline receptor controversy.

Brüss M, Bönisch H, Göthert M, Molderings GJ.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Mar;367(3):328-31. Epub 2003 Feb 14.

PMID:
12644907
34.
35.
36.

Ca2+ entry via P/Q-type Ca2+ channels and the Na+/Ca2+ exchanger in rat and human neocortical synaptosomes.

Fink K, Meder WP, Clusmann H, Göthert M.

Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):458-63. Epub 2002 Sep 6.

PMID:
12382075
37.

Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site.

Barann M, Molderings G, Brüss M, Bönisch H, Urban BW, Göthert M.

Br J Pharmacol. 2002 Nov;137(5):589-96.

38.

Exposure of rat isolated stomach and rats in vivo to [(14)C]agmatine: accumulation in the stomach wall and distribution in various tissues.

Molderings GJ, Heinen A, Menzel S, Göthert M.

Fundam Clin Pharmacol. 2002 Jun;16(3):219-25.

PMID:
12165069
39.

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.

Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, Göthert M.

Neuropharmacology. 2002 Feb;42(2):229-36.

PMID:
11804619
40.
41.
42.

Agmatine and putrescine uptake in the human glioma cell line SK-MG-1.

Molderings GJ, Bönisch H, Göthert M, Brüss M.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):671-9.

PMID:
11414662
43.

Novel histamine H(3)-receptor antagonists and partial agonists with a non-aminergic structure.

Nickel T, Bauer U, Schlicker E, Kathmann M, Göthert M, Sasse A, Stark H, Schunack W.

Br J Pharmacol. 2001 Apr;132(8):1665-72.

44.

Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms.

Brüss M, Barann M, Hayer-Zillgen M, Eucker T, Göthert M, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):392-401.

PMID:
11111833
45.

Nuclear factor-kappaB mediates simultaneous induction of inducible nitric-oxide synthase and Up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages.

Hammermann R, Dreissig MD, Mössner J, Fuhrmann M, Berrino L, Göthert M, Racké K.

Mol Pharmacol. 2000 Dec;58(6):1294-302.

PMID:
11093766
47.

Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects.

Barann M, Meder W, Dorner Z, Brüss M, Bönisch H, Göthert M, Urban BW.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):255-65.

PMID:
10997728
48.

Species-specific pharmacological properties of human alpha(2A)-adrenoceptors.

Molderings GJ, Bönisch H, Brüss M, Likungu J, Göthert M.

Hypertension. 2000 Sep;36(3):405-10.

PMID:
10988273
49.

Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation.

Molderings GJ, Menzel S, Kathmann M, Schlicker E, Göthert M.

Br J Pharmacol. 2000 Aug;130(7):1706-12.

50.

In rat alveolar macrophages lipopolysaccharides exert divergent effects on the transport of the cationic amino acids L-arginine and L-ornithine.

Messeri Dreissig MD, Hammermann R, Mössner J, Göthert M, Racké K.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Jun;361(6):621-8.

PMID:
10882037

Supplemental Content

Loading ...
Support Center